CN1319137A - 角质形成细胞衍生的干扰素 - Google Patents
角质形成细胞衍生的干扰素 Download PDFInfo
- Publication number
- CN1319137A CN1319137A CN99811157A CN99811157A CN1319137A CN 1319137 A CN1319137 A CN 1319137A CN 99811157 A CN99811157 A CN 99811157A CN 99811157 A CN99811157 A CN 99811157A CN 1319137 A CN1319137 A CN 1319137A
- Authority
- CN
- China
- Prior art keywords
- polypeptide
- leu
- seq
- kdi
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M145/00—Lubricating compositions characterised by the additive being a macromolecular compound containing oxygen
- C10M145/18—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C10M145/24—Polyethers
- C10M145/26—Polyoxyalkylenes
- C10M145/36—Polyoxyalkylenes etherified
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M145/00—Lubricating compositions characterised by the additive being a macromolecular compound containing oxygen
- C10M145/18—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C10M145/24—Polyethers
- C10M145/26—Polyoxyalkylenes
- C10M145/38—Polyoxyalkylenes esterified
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M173/00—Lubricating compositions containing more than 10% water
- C10M173/02—Lubricating compositions containing more than 10% water not containing mineral or fatty oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2209/00—Organic macromolecular compounds containing oxygen as ingredients in lubricant compositions
- C10M2209/10—Macromolecular compoundss obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C10M2209/103—Polyethers, i.e. containing di- or higher polyoxyalkylene groups
- C10M2209/108—Polyethers, i.e. containing di- or higher polyoxyalkylene groups etherified
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
- C10M2209/00—Organic macromolecular compounds containing oxygen as ingredients in lubricant compositions
- C10M2209/10—Macromolecular compoundss obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C10M2209/103—Polyethers, i.e. containing di- or higher polyoxyalkylene groups
- C10M2209/109—Polyethers, i.e. containing di- or higher polyoxyalkylene groups esterified
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Plant Pathology (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9364398P | 1998-07-21 | 1998-07-21 | |
US60/093,643 | 1998-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1319137A true CN1319137A (zh) | 2001-10-24 |
Family
ID=22240013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN99811157A Pending CN1319137A (zh) | 1998-07-21 | 1999-07-21 | 角质形成细胞衍生的干扰素 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1100902A4 (ko) |
JP (1) | JP2002522021A (ko) |
KR (1) | KR100688051B1 (ko) |
CN (1) | CN1319137A (ko) |
AU (1) | AU765890B2 (ko) |
CA (1) | CA2335655A1 (ko) |
NZ (1) | NZ509402A (ko) |
WO (1) | WO2000005371A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108752457A (zh) * | 2018-05-23 | 2018-11-06 | 华中农业大学 | 一种来源于草鱼干扰素的衍生多肽及其应用 |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE385517T1 (de) | 1999-12-08 | 2008-02-15 | Amgen Inc | Interferon ähnliche moleküle, und deren verwendungen |
EP1605045A3 (en) * | 2000-02-15 | 2006-03-01 | Curagen Corporation | Polypeptides and nucleic acids encoding same |
AU2001238303A1 (en) * | 2000-02-15 | 2001-08-27 | Curagen Corporation | Polypeptides and nucleic acids encoding same |
KR100975013B1 (ko) * | 2008-02-29 | 2010-08-09 | 김성일 | 원터치로 개폐되는 키홀더 |
KR200457865Y1 (ko) * | 2009-09-11 | 2012-01-05 | 한국알프스 주식회사 | 자동차용 키 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0626448A3 (de) * | 1993-05-26 | 1998-01-14 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Verfahren zur Herstellung und Reinigung von alpha-Interferon |
-
1999
- 1999-07-21 CA CA002335655A patent/CA2335655A1/en not_active Abandoned
- 1999-07-21 KR KR1020017000891A patent/KR100688051B1/ko not_active IP Right Cessation
- 1999-07-21 JP JP2000561317A patent/JP2002522021A/ja active Pending
- 1999-07-21 AU AU51161/99A patent/AU765890B2/en not_active Ceased
- 1999-07-21 CN CN99811157A patent/CN1319137A/zh active Pending
- 1999-07-21 WO PCT/US1999/016424 patent/WO2000005371A1/en active IP Right Grant
- 1999-07-21 NZ NZ509402A patent/NZ509402A/en unknown
- 1999-07-21 EP EP99935752A patent/EP1100902A4/en not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108752457A (zh) * | 2018-05-23 | 2018-11-06 | 华中农业大学 | 一种来源于草鱼干扰素的衍生多肽及其应用 |
Also Published As
Publication number | Publication date |
---|---|
AU5116199A (en) | 2000-02-14 |
KR100688051B1 (ko) | 2007-02-28 |
WO2000005371A1 (en) | 2000-02-03 |
JP2002522021A (ja) | 2002-07-23 |
CA2335655A1 (en) | 2000-02-03 |
EP1100902A1 (en) | 2001-05-23 |
EP1100902A4 (en) | 2004-09-29 |
AU765890B2 (en) | 2003-10-02 |
KR20010083132A (ko) | 2001-08-31 |
NZ509402A (en) | 2003-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1107072C (zh) | 编程性细胞死亡诱导分子ⅱ | |
CN1184315C (zh) | 包含死亡结构域的受体-5 | |
CN1125082C (zh) | 人类趋化因子β-8,趋化因子β-1和巨噬细胞炎性蛋白-4 | |
CN1214050A (zh) | 人肿瘤坏死因子δ和ε | |
CN1197966C (zh) | 肿瘤坏死因子受体相关因子的调节剂、及其制备和用途 | |
CN1335884A (zh) | 类白介素17受体蛋白 | |
CN1327452A (zh) | 具有肝细胞增殖活性的成纤维细胞生长因子 | |
CN1539970A (zh) | 嗜中性白细胞因子α | |
CN1131240C (zh) | 染色体21基因标记,组合物及其使用方法 | |
CN1186518A (zh) | 人血管内皮生长因子2 | |
CN1190991A (zh) | 人类趋化因子β-11和人类趋化因子α-1 | |
CN1099802A (zh) | 肿瘤坏死因子突变蛋白 | |
CN88100685A (zh) | 人的白细胞间素-3及其突变蛋白质 | |
CN1217024A (zh) | 趋化因子α-2 | |
CN1319137A (zh) | 角质形成细胞衍生的干扰素 | |
CN1246151A (zh) | 链球菌毒素a突变体及其使用方法 | |
CN1213401A (zh) | Exodus化学激活素物质及方法 | |
CN1760205A (zh) | 睫状神经营养因子(cntf)突变体及其生产方法和其用途 | |
CN1335889A (zh) | 编码l.infantum的四种蛋白质的抗原决定簇的嵌合基因 | |
CN1192751A (zh) | 单核细胞趋化蛋白-4 | |
CN1464057A (zh) | 具有骨骼肌刺激活性和免疫调节作用的趋化素样因子超家族 | |
CN1109505A (zh) | α/β-干扰素结合蛋白,制法及用途 | |
CN1163506C (zh) | 新的人细胞因子、其编码序列及用途 | |
CN1194012C (zh) | 精子生成相关蛋白、其编码序列及用途 | |
CN1216063A (zh) | 白细胞介素-6突变蛋白 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |